OLIVIA QUIDO FIRM & FADE I Cream contains hydroquinone, which may produce exogenous ochronosis, a gradual blue-black darkening of the skin, the occurrence of which should prompt discontinuation of therapy. (3) (3), OLIVIA QUIDO FIRM & FADE II Cream is contraindicated in individuals with a history of hypersensitivity to this product or any of its components. Its properties include exfoliation of dead skin and dry skin, or libag, so that when makeup is applied, "Makintab, glassy skin na.". Each gram of OLIVIA QUIDO FIRM & FADE II Cream contains 10.0 mg of hydrocortisone, 60.0 mg of hydroquinone, and 1.0 mg of tretinoin in a light yellow, hydrophilic cream base. Refrigeration recommended. The molecular formula is C20H28O2 and molecular weight is 300.44. (6), OLIVIA QUIDO FIRM & FADE II Cream contains the teratogen, tretinoin, which may cause embryofetal death, altered fetal growth, congenital malformations, and potential neurologic deficits. See our results and our customer testimonials Subscribe to Drugs.com newsletters for the latest medication news, new drug approvals, alerts and updates. (4) (4), If anaphylaxis, asthma or other clinically significantly hypersensitivity reactions occur, institute appropriate therapy and discontinue OLIVIA QUIDO FIRM & FADE II Cream. WARNING OLIVIA QUIDO FIRM & FADE I Cream is contraindicated in individuals with a history of hypersensitivity to this product or any of its components. (5), In case of adverse reaction, call a doctor. It is not for oral, ophthalmic, or intravaginal use. The use of F&F differs from the famous Korean 10-step skin-care routine. OLIVIA QUIDO FIRM & FADE II Cream is a combination of hydrocortisone (a corticosteroid), hydroquinone (a melanin synthesis inhibitor), and a tretinoin (a retinoid) that is indicated for the gradual bleaching of hyperpigmented skin conditions age and liver spots, freckles, and other unwanted areas of melanin hyperpigmentation, in the presence of measures for sun avoidance, including the use of sunscreen. Clinical Trials, Its molecular formula is C21H30O5 ; its molecular weight is 362.46; its Chemical Abstract Service (CAS) registry number is 50-23-7. Olivia Quido Firm and Fade Cream. Hindi ko na alam if may pag-asang lumabas kasi parang butas ng karayom dadaanan mo dito, e.". Citations. The carcinogenic potential of hydroquinone in humans is unknown. Tretinoin has been shown to be negative for mutagenesis in the Ames assay. Patients should avoid medicated or abrasive soaps and cleansers, soaps and cosmetics with drying effects, products with high concentrations of alcohol and astringents, and other irritants or keratolytic drugs while on OLIVIA QUIDO FIRM & FADE II Cream treatment. Out of scope information includes radiopharmaceuticals, contrast media, herbals, homeopathics, and food. She told PEP.ph, Siguro sabi ni Lord, hindi iyan ang para sa iyo, maghintay ka lang.". Use OLIVIA QUIDO FIRM & FADE II Cream as directed by the health care provider and do not use OLIVIA. OLIVIA QUIDO FIRM & FADE I Cream is for topical use only. (1) (1), Apply a thin film to the affected area once daily at night or as directed by a doctor. "Siya iyong isang prescription product owned by a Filipino sa America. The F&F has the 10-digit or 11-digit NDC (National Drug Code) numbera three-segment universal product identifier for human drugs in the U.S. that identifies the labeler, the product, and the commercial package size. Events, There have been no systemic reactions reported from the use of topical hydroquinone. If anaphylaxis, asthma or other clinically significantly hypersensitivity reactions occur, institute appropriate therapy and discontinue OLIVIA QUIDO FIRM & FADE I Cream. PubMed, Tretinoin, a retinoid, is all-trans-retinoic acid formed from the oxidation of the aldehyde group of retinene to a carboxyl group. Even her eyes were smiling when she revealed that one of her productsSecret Gold 24K Maskgot included on the list of "Effective Gold-Infused skincare products," an article published on, F&F, short for the OLIVIA QUIDO FIRM & FADE II Cream. If anaphylaxis, asthma or other clinically significantly hypersensitivity reactions occur, institute appropriate therapy and discontinue OLIVIA QUIDO FIRM & FADE II Cream. OLIVIA QUIDO FIRM & FADE I Cream is contraindicated in individuals with a history of hypersensitivity to this product or any of its components. It is not for oral, ophthalmic, or intravaginal use. Occasional hypersensitivity (localized contact dermatitis) may occur, in which case the medication should be discontinued and the physician notified immediately. "Naghanap ako ng isang formula na makaka-treat niyang dalawa. Allergic contact dermatitis may also occur. 2023 Philippine Entertainment Portal Inc. 2023 Philippine Entertainment Portal Inc. All Rights Reserved. Since this product contains no sunscreen, an effective broad spectrum sun blocking agent should be used and unnecessary solar exposure avoided, or protective clothing should be worn to cover bleached skin in order to prevent repigmentation from occurring. Seek medical attention if you, experience allergic contact dermatitis, blistering, crusting, and severe burning or swelling of the skin and irritation. OLIVIA QUIDO FIRM & FADE I Cream is for topical use only. Patients who are consistently exposed to sunlight or, skin irritants either through their work environment or habits should exercise particular caution. Due to inconsistencies between the drug labels on DailyMed and the pill images provided by RxImage, we no longer display the RxImage pill images associated with drug labels. Rx ONLY. Treatment with hydroquinone has resulted in positive findings for genetic toxicity in the Ames assay in bacterial strains sensitive to oxidizing mutagens, in in vitro studies in mammalian cells, and in the in vivo mouse micronucleus assay. Teratogenic Effects: Pregnancy Category C. In general, use of drugs should be reduced to a minimum in pregnancy. OLIVIA QUIDO FIRM & FADE I Cream is a combination of hydrocortisone (a corticosteroid), hydroquinone (a melanin synthesis inhibitor), and a tretinoin (a retinoid) that is indicated for the gradual bleaching of hyperpigmented skin conditions age and liver spots, freckles, and other unwanted areas of melanin hyperpigmentation, in the presence of measures for sun avoidance, including the use of sunscreen. OSKIN Pharmas Firm & Fade products are prescription skin lightening creams that allow you to enjoy superb blemish and pigmentation correction, SPF 30 UV protection and moisturization all in a single, skin-perfecting lightening product. Tretinoin is considered to be highly teratogenic upon systemic administration. OLIVIA QUIDO FIRM & FADE I Cream is for topical use only. We anticipate reposting the images once we are able identify and filter out images that do not match the information provided in the drug labels. An NDC approval means a product can be sold to other doctors as well. No systemic adverse reactions have been reported. We use cookies to ensure you get the best experience on PEP.ph. Biochemical Data Summary. Gently wash the face and neck with a mild cleanser. Mutagenicity studies were not conducted with this combination of active ingredients. Studies of hydroquinone in animals have demonstrated some evidence of carcinogenicity. 88436-1 - Section Title Not Found In Database, Report Adverse However, exposure during the period of organogenesis in the first trimester is theoretically more likely to produce adverse outcome than in later pregnancy. It occurs as yellow to light orange crystals or crystalline powder with a characteristic odor of ensilage. The risk of teratogenesis due to topical exposure to OLIVIA QUIDO FIRM & FADE II Cream may be considered low. In 2012, she opened her second branch in Eagle Rock Plaza Mall, Los Angeles. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy. Dosage form: cream OLIVIA QUIDO FIRM & FADE II Cream contains hydroquinone and tretinoin that may cause mild to moderate irritation. Patients should avoid medicated or abrasive soaps and cleansers, soaps and cosmetics with drying effects, products with high concentrations of alcohol and astringents, and other irritants or keratolytic drugs while on OLIVIA QUIDO FIRM & FADE I Cream treatment. Storage: Keep tightly closed. Last year, her skin-care label became one of the brand partners of the Miss Universe and Miss USA organizations. It is not for oral, ophthalmic, or intravaginal use. Keep tightly closed. Avoid use of medications that are known to be photosensitizing. Additional information regarding the genetic toxicity potential of tretinoin is not available. Care should be taken to avoid contact between the infant being nursed and OLIVIA QUIDO FIRM & FADE I Cream. Updated Manifestations of Cushings syndrome, hyperglycemia, and glucosuria can also be produced by systemic absorption of topical corticosteroid while treatment. If a reaction suggests hypersensitivity or chemical irritation, discontinue use of the medication and call a doctor. Last updated on Feb 20, 2023. OLIVIA QUIDO FIRM & FADE I Cream contains 1% of hydrocortisone, USP, 8% of hydroquinone, USP, and 0.1% of tretinoin, USP, in a light yellow, hydrophilic cream base for topical application. These highlights do not include all the information needed to use OLIVIA QUIDO FIRM & FADE II Cream safely and effectively. Hydrocortisone sodium succinate has the same metabolic and anti-inflammatory actions as hydrocortisone. Each gram of OLIVIA QUIDO FIRM & FADE I Cream contains 10.0 mg of hydrocortisone, 80.0 mg of hydroquinone, and 1.0 mg of tretinoin in a light yellow, hydrophilic cream base. Local irritation, such as skin reddening, peeling, mild burning sensation, dryness, and pruritus may be expected at the site of application. Report Adverse Corticosteroids, when systemically administered, appear in human milk. To view updated drug label links, paste the RSS feed address (URL) shown below into a RSS reader, or use a browser which supports RSS feeds, such as Safari for Mac OS X. Olivia Quido Firm and Fade Prescribing Information, hydrocortisone, hydroquinone, tretinoin cream. Because many drugs are secreted in human milk, caution should be exercised when OLIVIA QUIDO FIRM & FADE II Cream is administered to a nursing woman. If local irritation persists or becomes severe, discontinue application of the medication and consult your health care provider. of melasma therapy, as even minimal sunlight sustains melanocytic activity. If the medication is applied excessively, marked redness, peeling, or discomfort may occur. 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility. Because of the drying effect of this medication, a moisturizer may be applied to the face in the morning after washing. Package insert / product label Gently wash the face and neck with a mild cleanser. If HPA axis suppression is noted, the use of OLIVIA QUIDO FIRM & FADE II Cream should be discontinued. Most of the clients, eighty to eighty-five percent, dalawa lang ang problemamay taghiyawat or may itim sa mukha. Since this product contains no sunscreen, an effective broad spectrum sun blocking agent should be used and unnecessary solar exposure avoided, or protective clothing should be worn to cover bleached skin in order to prevent repigmentation from occurring. Animal reproductive studies are not available with topical hydroquinone. Available for Android and iOS devices. Chemically, hydrocortisone is pregn-4-ene-3,20-dione, 11, 17,21-trihydroxy-, (11)-. In a Zoom videocon, PEP.ph learned a thing or two about skin care. Patients are cautioned on concomitant use of medications that are known to be photosensitizing. Inactive: aloe barbadensis leaf powder, ascorbic acid, BHT, C13-14 isoparaffin, caprylic/capric triglyceride, cetyl alcohol, cyclopentasiloxane, diazolidinyl urea, dimethicone crosspolymer, dimethyl isosorbide, ethylhexyl stearate, glycerin, iodopropynyl butylcarbamate, kojic acid, laureth-7, maltodextrin, PEG/PPG-18/18 dimethicone, pentaclethra macroloba seed oil, phenoxyethanol, polyacrylamide, polyacrylate-13, polyisobutene, polysorbate 20, polysorbate 80, propylene glycol, purified water, sodium lauryl sulfate, stearyl alcohol, tocopherol, tocopheryl acetate, triethylene glycol, white petrolatum. Events, (What If a patient has been inadvertently exposed to OLIVIA QUIDO FIRM & FADE I Cream in pregnancy, she should be counseled on the risk of teratogenesis due to this exposure. The Pinay esthetician said, "Hindi nakukuha iyan basta-basta. (8.1) (8). Chemically, hydrocortisone is pregn-4-ene-3,20-dione, 11, 17,21-trihydroxy-, (11)-. Ayaw kong umaalis ng bahay na hindi nakaayos.". (6) (6), To report SUSPECTED ADVERSE REACTIONS, contact FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. "Or lipstick ng mama ko, kinukuha ko. Ms. O herself was chosen by the Miss Universe Chile pageant as one of its judges. OLIVIA QUIDO FIRM & FADE II Cream contains hydroquinone, which may produce exogenous ochronosis, a gradual blue-black darkening of the skin, the occurrence of which should prompt discontinuation of therapy. OLIVIA QUIDO FIRM & FADE I Cream contains 1% of hydrocortisone, USP, 8% of hydroquinone, USP, and 0.1% of tretinoin, USP, in a light yellow, hydrophilic cream base for topical application. She said, "Eto na talaga pinaka-passion ko. Drug names that are ambiguous or not compatible with the RxNorm system, such as multivitamins with more than 4,000 characters in their names, are also out of scope. The risk of teratogenesis due to topical exposure to OLIVIA QUIDO FIRM & FADE I Cream may be considered low. Files, Presentations Some corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. Sa lahat ng ginawa ko, eto iyong number na pinakamahirap makuha. The molecular formula is C6H6O2 and molecular weight is 110.11. The molecular formula is C6H6O2 and molecular weight is 110.11. Apply a thin film of OLIVIA QUIDO FIRM & FADE I Cream to the affected area once daily at night or as directed by a doctor. During the day, use O Skin Sunscreen SPF-50, and wear protective clothing. Animal reproductive studies are not available with topical hydroquinone. If local irritation persists or becomes severe, discontinue application of the medication and consult your health care provider. Tretinoin has been shown to be negative for mutagenesis in the Ames assay. Allergic contact dermatitis may also occur. It is not known whether topical application of OLIVIA QUIDO FIRM & FADE II Cream could result in sufficient systemic absorption to produce detectable quantities of hydrocortisone, hydroquinone, or tretinoin in human milk. ", Ms. O revealed, "Dalawa ang paulit-ulit sa mga 10 problems, eto lang talaga. March 22, 2021. OLIVIA QUIDO FIRM & FADE II Cream is for topical use only. If you no longer wish to have this DailyMed RSS service, simply delete the copied URL from your RSS Reader. QUIDO FIRM & FADE II Cream for any disorder other than that for which it is prescribed. We comply with the HONcode standard for trustworthy health information. Doctor lang ang puwede magbenta nito sa America. QUIDO FIRM & FADE I Cream for any disorder other than that for which it is prescribed. OLIVIA QUIDO FIRM & FADE I Skin Lightener Cream. Patients should avoid medicated or abrasive soaps and cleansers, soaps and cosmetics with drying effects, products with high concentration of alcohol and astringent, and other irritants or keratolytic drugs while on OLIVIA QUIDO FIRM & FADE II Cream treatment. A peek into Olivia Quido-Co's journey as spa owner in the US - PEP.ph During the day, use O Skin Sunscreen SPF-50, and wear protective clothing. Rinse and pat the skin dry. Weather extremes, such as heat or cold, may be irritating to patients treated with OLIVIA QUIDO FIRM & FADE. For the gradual bleaching of hyperpigmented skin conditions such as age and liver spots, freckles, and other unwanted areas of melanin hyperpigmentation. Safety and effectiveness of OLIVIA QUIDO FIRM & FADE I Cream in pediatric patients have not been established. Occasional hypersensitivity (localized contact dermatitis) may occur, in which case the medication should be discontinued and the physician notified immediately. The carcinogenic potential of hydroquinone in humans is unknown. Tretinoin 0.1% Even her eyes were smiling when she revealed that one of her productsSecret Gold 24K Maskgot included on the list of "Effective Gold-Infused skincare products," an article published on Forbes. Allergic contact dermatitis may also occur. Avoid sunlight exposure to prevent repigmentation. O SKIN Pharmaceutical - Olivia Quido This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Files, All Mapping Each gram of OLIVIA QUIDO FIRM & FADE I Cream contains 10.0 mg of hydrocortisone, 80.0 mg of hydroquinone, and 1.0 mg of tretinoin in a light yellow, hydrophilic cream base. Safety and effectiveness of OLIVIA QUIDO FIRM & FADE II Cream in pediatric patients have not been established. It occurs as yellow to light orange crystals or crystalline powder with a characteristic odor of ensilage. 3 DOSAGE FORMS AND STRENGTHS Cream, 1%/6%/0.1%. Kasi bata pa lang ako, iyong pera na binibigay sa akin na pambili ng merienda, lotion ang binibili ko. Mutagenicity studies were not conducted with this combination of active ingredients. FDA Safety Recalls, 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility. (current). No studies of fertility and early embryonic toxicity of this drug product has been performed. It occurs as fine white needles that darken on exposure to air. DOSAGE & ADMINISTRATION DOSAGE AND ADMINISTRATION - Gently wash the face and neck with a mild cleanser. OLIVIA QUIDO FIRM & FADE II Cream contains 1% of hydrocortisone, USP, 6% of hydroquinone, USP, and 0.1% of tretinoin, USP, in a light yellow, hydrophilic cream base for topical application. More about Olivia Quido Firm and Fade (hydrocortisone / hydroquinone / tretinoin topical) Check interactions Compare alternatives Drug class: topical depigmenting agents Professional resources Prescribing Information Further information